View abstract

Cet abstract a été assigné à session Ped & Low - Pediatric Ophthalmology and Low-Vision
TitreMedical glaucoma treatment in children
Abstract Nr.1077
ButThe indications and side effects of topical and systemic anti-glaucoma treatment in children are described.
MéthodesA review of literature is performed and an algorithm of medical treatment in children with glaucoma is described.
RésultatsChildren are at a higher risk of systemic, potentially fatal side effects from topical administration. Measurements to reduce systemic absorption need to be taken. It is important to prescribe the minimum frequency and lowest concentration of a given glaucoma drug that is needed to achieve the target intraocular pressure.

The medical therapy of pediatric glaucoma can be divided in five groups: beta-blockers, prostaglandin analogs, carbonic anhydrase inhibitors, sympathomimetics and miotics.
Indications and potential side effects will be discussed.
ConclusionMedical therapy plays an important role in childhood glaucoma; the indication for a specific treatment depends on the type of glaucoma, as well as specific features of the affected child and eyes. Beta-blockers are considered the first-line therapy, whereas carbonic anhydrase inhibitors are the second-line therapy. Recent evidence from a RCT in a pediatric population indicates that prostaglandin analogues are not inferior to beta-blockers and have minimal systemic side effects. This makes them a valid alternative for first line therapy.
Conflit d'intérêtNon
Auteur 1
NomODENT
InitialesS
InstitutUZLeuven
VilleLeuven
Auteur 2
NomCassiman
InitialesC
InstitutUZLeuven
VilleLeuven
Auteur 3
NomVandewalle
InitialesE
InstitutUZLeuven
VilleLeuven
Auteur 4
NomStalmans
InitialesI
InstitutUZLeuven
VilleLeuven
Auteur 5
NomCasteels
InitialesI
InstitutUZLeuven
VilleLeuven
top ^